
Introduction Clade I is becoming more predominant in Europe and may differ epidemiologically from Clade II. Methods This case–case study (N=100) compared Clades I and II detected in Barcelona between September 2025 and June 2026. Crude and adjusted odds ratios (aOR) with 95% confidence intervals (95%CI) were estimated using logistic regression models. Results While the overall epidemiological profile and clinical severity were similar, Clade I cases were more likely to reside in lower-income districts, less likely to be migrants (aOR=0.34, 95%CI 0.25;0.47), and more frequently reported sexual activity during leisure activities(aOR=7.55, 95%CI 3.93;14.53), attendance at large-scale events(aOR=18.78, 95%CI 7.40;47.67). Clinically, Clade I cases showed higher odds of fever (aOR=1.55, 95%CI 1.05;2.28), odynophagia (aOR=5.13, 95%CI 2.98;8.85), oral rash (aOR=42.60, 95%CI 12.11;149.88) and generalized rash, whereas generalized lymphadenopathy (aOR=0.33, 95%CI 0.15;0.71) and anogenital rash (aOR=0.55, 95%CI 0.36;0.83) were less frequent. Conclusions These findings suggest that Clade Ib circulation in urban settings currently mirrors the epidemiological patterns established by Clade IIb.
Introduction: Respiratory viral infections are a major cause of hospitalization, morbidity, mortality, and healthcare resource use in Spain. Although influenza and respiratory syncytial virus (RSV) account for most of the healthcare burden, the contribution of other respiratory viruses has been less studied. This study aimed to analyze the hospital burden, clinical severity, and economic impact of these infections during the 2019-2023 period. Methods: A retrospective population-based study was conducted using the Spanish Minimum Basic Data Set (CMBD), including hospitalizations with a diagnosis of respiratory viral infection between 2019 and 2023. Influenza, RSV, adenovirus, metapneumovirus, parainfluenza, and rhinovirus were analyzed. Results: A total of 154,753 hospitalizations were included (mean age: 39 years; 48.6% female). Influenza and RSV accounted for most hospitalizations and total costs. A marked reduction in hospitalizations was observed in 2021, followed by recovery in 2022-2023. RSV, metapneumovirus, rhinovirus, and adenovirus predominantly affected the pediatric population, whereas influenza and parainfluenza had a greater impact on older adults. Overall, 6.5% of patients required ICU admission and in-hospital mortality was 2.7%, highest for influenza (4.2%). Metapneumovirus and rhinovirus showed the highest ICU admission rates. Mean hospital stay was 6.1 days (7.4 days in ICU). Although influenza and RSV generated the highest total costs, other viruses showed higher costs per episode. Conclusions: Respiratory viral infections impose a substantial healthcare and economic burden, with variable impact according to virus type and age group, highlighting the need for integrated surveillance, prevention, and healthcare planning strategies.
Introduction: Actinotignum is a genus of gram-positive bacteria mainly involved in urinary tract infections and invasive infections such as bacteremia. The aim of this study was to analyse clinically and microbiologically the episodes of bacteremia caused by Actinotignum spp. Methods: A retrospective descriptive study was conducted, including all episodes of Actinotignum spp. bacteremia in Navarra between 2014 and 2024. Clinical, demographic, and microbiological data were analysed. Results: Twenty-eight episodes were described. Twenty-six occurred in men with a mean age of 77 years. The urinary tract was the source of bacteremia in 92.8% of cases. Despite that, Actinotignum sp. was isolated in urine in a single case. Conclusions: Actinotignum spp. bacteremia was predominantly of urinary origin and mainly affected elderly patients with underlying urological disease. Active screening for Actinotignum in selected urine samples may help reduce the underdiagnosis of urinary tract infections caused by this microorganism and its complications, such as bacteremia.